Sebastian Brennan

Senior Principal Pathologist
BioMarin Pharmaceutical, Novato, United States
Novato, California, United States

Presentation(s):

• PB0221 - Persistent and stable therapeutic levels of transgenic FVIII expression following AAV delivery to adult and infant hemophilic dogs

  Sunday, June 23, 2024
  13:45 – 14:45 ICT